Based on the studies in vitro on the proliferation and differentiation of OPCs, we decided to check the effects of LRRK2 inhibitor 4 in vivo, using the experimental autoimmune encephalomyelitys (EAE) murine model of MS. Here, LRRK2 is linked to myeloid sarcoma.